Tirzepatide is one Lilly drug with two brand names, Zepbound for weight and sleep apnea and Mounjaro for type 2 diabetes, given as a weekly shot that acts on GIP and GLP-1 receptors.
Four routes Tampa patients use
Most people in Tampa land on one of four routes. Cash buyers order Zepbound from LillyDirect. Insured patients fill Zepbound or Mounjaro at a local pharmacy under their plan. Eligible Medicare enrollees use the Bridge. The fourth route, compounded tirzepatide sold by some clinics, is not FDA-approved [7]. Age and diagnosis steer the choice: 13.7% of Tampa residents are 65 or older [4], and among the city's adults 12.5% have diagnosed diabetes and 31.9% live with obesity [5].
Sponsored placement: open.
One local practice can be featured here. This is a paid, labeled placement and never an endorsement.
Feature your practice in Tampa, from $300 a month.
That box is advertising space a Tampa practice can buy. It always carries a label, and buying it never buys a recommendation.
KwikPen or vial in Hillsborough County
Lilly launched a four-dose Zepbound KwikPen on February 23, 2026, one pen per month of weekly shots [8]. LillyDirect prices it the same as the vial [1]. If you pay cash, pick the form you find easier to handle. On Medicare Part D the form decides coverage: the Bridge accepts only the KwikPen and turns away single-dose vials and pens [2]. Humana runs the Bridge's prior authorization and is meant to decide within 72 hours [2]. Our Medicare GLP-1 guide lists who qualifies.
What Tampa cash buyers pay, strength by strength
| Strength or program | Per month | Fine print |
|---|---|---|
| Starter strength, 2.5 mg | $299 [1] | Four weeks only; the label then steps the dose up [16] |
| Second step, 5 mg | $399 [1] | Pen and vial priced alike |
| 7.5 mg and up, refilled within 45 days | $449 [1] | Later refill: $499 at 7.5 mg, $699 at 10 to 15 mg |
| Medicare GLP-1 Bridge, eligible Part D members | $50 [3] | Wegovy, Foundayo and the Zepbound KwikPen |
| Zepbound with no discount | $1,087 [9] | Original price shown on TrumpRx |
Tampa adults with diabetes: the Mounjaro side
Mounjaro is the same molecule under a diabetes label: blood sugar control in type 2 diabetes for adults and children 10 and older, plus lowering the risk of major heart events in high-risk adults who have type 2 diabetes [10]. Lilly lists it at $1,112.16 for 28 days [11], and a commercially insured patient using the savings card may pay as little as $25 [12]. Label differences are laid out in Mounjaro vs Zepbound.
If a Tampa clinic quotes compounded tirzepatide
FDA has taken tirzepatide off its shortage list and closed the grace periods that once let compounders copy it in bulk [13]. It has also told telehealth sellers not to call compounded products generic or the same as approved drugs [14]. Ask any clinic with a low quote which pharmacy makes the product, then look that pharmacy up with the Florida Board of Pharmacy [15]. FDA does not review compounded drugs for safety, effectiveness or quality [7]. Background: compounded tirzepatide.
Trial averages, briefly
Adults without diabetes in SURMOUNT-1 averaged a 20.9% drop in body weight at 72 weeks on 15 mg (19.5% on 10 mg, 15.0% on 5 mg) while the placebo group averaged 3.1% [17]. SURMOUNT-4 tested stopping: people moved to placebo after 36 weeks regained 14.0% of body weight over the next year, and those kept on the drug lost a further 5.5% [18]. Neither figure predicts one person's result; see tirzepatide results.
Before a Tampa patient starts
Skip tirzepatide if you or a close relative has had medullary thyroid carcinoma, or if you have MEN 2; the boxed warning concerns thyroid C-cell tumors seen in rats. Belly pain that is severe and does not ease can mean pancreatitis, so stop the drug and get seen. Face or throat swelling or trouble breathing can signal an allergic reaction. Pairing it with insulin or a sulfonylurea raises the odds of low blood sugar. Stop it if you become pregnant, and tell the anesthesia team before any procedure [16]. For anything that feels like an emergency, call 911.
Elsewhere in Florida: Orlando tirzepatide costs, Miami and Boca Raton. Across the bay, our St. Petersburg weight loss guide covers clinic programs. New to the drug? Start with the tirzepatide overview.
Questions people ask
Can Tampa patients pick up a LillyDirect order locally?
Yes. LillyDirect ships self-pay Zepbound free to your home or sends it to a Walmart Pharmacy for free pickup, at $299 to $449 a month by dose, checked Oct 17, 2026 [1].
I am on Medicare in Tampa. Which Zepbound form should I ask for?
Does Florida Medicaid pay for tirzepatide for weight loss in Hillsborough County?
No. Florida was not among the 13 state Medicaid programs covering GLP-1s for obesity in KFF's January 2026 count [6].
How common are diabetes and obesity among Tampa adults?
CDC PLACES estimates that in 2023, 12.5% of adults in the city of Tampa had diagnosed diabetes and 31.9% had obesity [5].
Who licenses the pharmacy behind a compounded tirzepatide offer in Tampa?
Does the KwikPen cost more than the vial?
No. LillyDirect charges the same self-pay price for both forms: $299 at 2.5 mg, $399 at 5 mg and $449 at 7.5 to 15 mg with on-time refills [1].
What happened when people stopped tirzepatide in a trial?
In SURMOUNT-4, people switched to placebo after 36 weeks regained an average of 14.0% of body weight over the next year [18].
Sources
18 cited
- Zepbound self-pay pricing. Eli Lilly and Company (LillyDirect), accessed 2026-10-17.
- Medicare GLP-1 Bridge: information for pharmacies. Centers for Medicare & Medicaid Services, accessed 2026-10-17.
- Weight loss drugs coverage. Medicare.gov (CMS), accessed 2026-10-17.
- QuickFacts: Tampa city, Florida. U.S. Census Bureau, QuickFacts, V2025; ACS 2020-2024.
- PLACES place data: Tampa, FL. CDC PLACES (2025 release, BRFSS 2023), 2023 data, 2025 release.
- Medicaid Coverage of and Spending on GLP-1s. KFF, Jan 16, 2026.
- FDA's concerns with unapproved GLP-1 drugs used for weight loss. US Food and Drug Administration, Oct 1, 2026.
- Lilly adds multidose Zepbound pens to self-pay menu. Fierce Pharma, Feb 23, 2026.
- TrumpRx.gov. TrumpRx.gov (US government), accessed 2026-10-17.
- Mounjaro label. DailyMed, NLM, Aug 2026.
- Mounjaro FAQ: pricing. Eli Lilly and Company, accessed 2026-10-17.
- Mounjaro savings resources. Eli Lilly and Company, accessed 2026-10-17.
- FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize. US Food and Drug Administration, Apr 1, 2026.
- FDA: what telehealth companies should know when promoting compounded drugs. US Food and Drug Administration, Jun 15, 2026.
- Florida Board of Pharmacy. Florida Department of Health, accessed 2026-10-17.
- Zepbound prescribing information. US FDA (accessdata.fda.gov), Apr 2026.
- Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). New England Journal of Medicine (PubMed), Jun 4, 2022.
- Continued treatment with tirzepatide for maintenance of weight reduction (SURMOUNT-4). JAMA (PubMed), Jan 1, 2024.
This page is general information, not medical advice. Talk with a licensed clinician about your own care.